• 3D MODEL:  Creation and validation of a 3D microphysiological disease model of human atrial conduction.  Timothy Smith, DPhil., MD.  Washington University.
  • CNCR REGISTRY:  A multi-center registry looking at patient outcomes for patients treated with cardiac radioablation.  Pamela Samson, MD.  Washington University. 
  • FACT-CRT:  Factors associated with response to cardiac resynchronization therapy in heart failure patients with non-LBBB ECG pattern.  Marye Gleva, MD.  University of Rochester.
  • IVTCC:  A multicenter ventricular tachycardia catheter ablation registry.  Daniel Cooper, MD.  UCLA.
  • LEADR:  Lead evaluation for defibrillation and reliability.  Timothy Smith DPhil., MD.  Medtronic.
  • MECHANISTIC BASIS OF CARDIAC IRRADIATION:  Mechanistic basis of cardiac irradiation as a therapy for ventricular tachycardia.  Stacey Rentschler, MD, PhD.  Washington University.
  • LIBREXIA AF:  A phase 3 study evaluating the safety and efficacy of milvexian versus apixaban in subjects with atrial fibrillation.   Marye Gleva, MD.  Janssen  Pharmaceuticals.
  • MVET/PERSONALIZING CLASS I ANTI-ARRHYTHMIC DRUG THERAPY:  Mexiletine ventricular tachycardia registry.  Jennifer Silva, MD., Jonathan Moreno MD, PhD, Jon Silva PhD, FAHA.  Washington University.
  • PAN:  Medtronic product surveillance registry.  Mitchell Faddis, MD, Ph.D.  Medtronic.
  • RADIATE-VT:  A study evaluating the safety and efficacy of cardiac radioablation compared to catheter ablation in patients with ventricular tachycardia. Daniel Cooper, MD.  Varian Medical Systems. (pending)
  • RESTART:  Re-ablation using a tailored approach targeting EGM-dispersion.  Daniel Cooper, MD.  Volta Medical.
  • SYNC AV:  A multicenter trial determining whether cardiac resynchronization therapy devices programmed with SyncAV ON improve long-term CRT response compared to devices programmed with conventional CRT.  Timothy Smith, DPhil., MD.  Abbott.
  • TAILORED AF:  Tailored versus anatomical ablation strategy for persistent AF.  Daniel Cooper, MD.  Volta Medical.
  • TRAVERSE:   Transseptal versus retrograde approach for ablation procedures involving left-sided arrhythmias (VT and PVC) to reduce emboli and neurocognitive decline in adults.   Daniel Cooper, MD.  UCSF.